TrialCancer medicine2023

Efficacy and safety of abemaciclib alone and with PI3K/mTOR inhibitor LY3023414 or galunisertib versus chemotherapy in previously treated metastatic pancreatic adenocarcinoma: A randomized controlled trial.

E Gabriela Chiorean et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.